Ultrasound Microbubble Lymphatic Flow Stimulation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current cancer treatments, such as prostate cancer therapy, face challenges in overcoming immunologic tolerance and enhancing immune responses against cancer cells, particularly due to the presence of immune-suppressive molecules and low lymphatic drainage in tumors, which limits the effectiveness of immunotherapy and radiation therapy in reaching metastatic sites.
Innovation Solution
The use of ultrasound vibrations of intra-capillary micro-bubbles to increase the outflow of lymphatic fluid containing tumor-associated antigen (TAA)-loaded dendritic cells from primary tumors to draining lymph nodes, enhancing both local and abscopal immune responses by increasing lymphatic flow and interstitial pressure, and breaking down extracellular matrix components to improve antigen presentation and immune cell trafficking.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If radiation therapy is applied to the primary tumor, then tumor cell death and antigen release are improved, but lymphatic drainage efficiency remains insufficient to transport enough antigens to draining lymph nodes
Solution Approach 1:
The patent applies mechanical vibration through ultrasound to microbubbles within the tumor vasculature. The oscillating microbubbles generate acoustic radiation force and micro-streaming effects that mechanically disrupt the extracellular matrix and enhance lymphatic fluid flow, thereby improving antigen transport from the primary tumor to draining lymph nodes.
Solution Approach 2:
The patent employs periodic ultrasound pulses to drive microbubble oscillation. This periodic action creates cyclic acoustic radiation force and micro-streaming patterns that continuously enhance lymphatic drainage efficiency, allowing sustained antigen transport to draining lymph nodes throughout the treatment period.
2Reliability
If immune-suppressive molecules like TGFb are present in prostatic cells, then T-cell access and cytotoxic responses are hindered, but the prostate remains a non-essential organ with slow proliferating tumor kinetics
Solution Approach 1:
The patent uses microbubbles as intermediaries that, when activated by ultrasound, generate acoustic radiation force and micro-streaming effects. These physical mechanisms temporarily disrupt the immunosuppressive microenvironment by enhancing lymphatic flow and antigen presentation, allowing immune cells to overcome the barrier created by molecules like TGFb and access tumor cells more effectively.
3Measurement precision
If ultrasound frequency is increased to improve imaging resolution, then microbubble vibration for lymphatic stimulation decreases
Solution Approach 1:
The patent segments the ultrasound application into two distinct frequency components: a low-frequency component (20-100 kHz) that resonates with microbubbles to drive lymphatic fluid flow and antigen transport, and a high-frequency component (>2 MHz) that provides imaging resolution. This frequency segmentation allows both therapeutic and diagnostic functions to operate simultaneously without interference.
Solution Approach 2:
The patent merges therapeutic ultrasound (low-frequency microbubble activation) and diagnostic ultrasound (high-frequency imaging) into a single integrated system. By combining these two ultrasound modalities with different frequency ranges, the system achieves both enhanced lymphatic drainage for antigen transport and high-resolution imaging of the primary tumor and draining lymph nodes.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach stimulates the production of tumor-specific CD8+ and CD4+ T-cells, increasing immune responses against primary and metastatic tumors, and enhances the delivery of cytotoxic T-cells to cancer sites, thereby improving treatment efficacy and extending survival in prostate cancer patients.
Implementation Method 1
means for vibrating said micro bubbles with incident ultrasound beams with appropriate frequency and amplitude
Implementation Method 2
one or both of the extra-capillary acoustic radiation force (ARF) and micro-shear waves produced by intra-capillary vibrating micro-bubbles
Data Source
Figure 1
Figure 2a~2b
Figure 3a~3b
AI summary
Ultrasound instrumentation for increasing the immune response to a given cancer in a patient through increasing lymphatic flow out of the cancer region, following a primary action of the cancer that loads professional antigen-presenting cells/dendritic cells (APCs/ DCs) with tumor-associated antigen (TAA) from the tumor into the interstitial fluid of the cancer region. Example primary actions are radio-therapy, and chemical- or radiopharmaceutical therapy. Intra¬ capillary micro-bubbles 109 in the tumor are brought to vibrate with incident ultrasound of appropriate frequency and amplitude, producing vibrations in the extra capillary tissue that produces an outward acoustic radiation force and micro shear waves in the tissue that increases transport of the interstitial fluid. This increases an outward flow from the proximal capillaries, increasing the interstitial fluid pressure that increases lymphatic outflow including APCs/DCs with TAA to primary draining lymph nodes (DLNs).